Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium - Concepedia

Concepedia

Publication | Closed Access

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

191

Citations

32

References

2000

Year

Joaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares, J.L. González-Larriba, Joan Carles, E. Batiste-Alentorn, A. Sáenz, M. López-Brea, Albert Font, Miguel Nogué,

Journal of Clinical Oncology

Abstract

This combination of paclitaxel, cisplatin, and gemcitabine is feasible and highly active in patients with advanced TCC of the urothelium. Further evaluation of this regimen in patients with TCC is warranted.

References

	Year	Citations

Page 1